Explore the latest developments concerning Pfizer Reports Earnings.
Pfizer (PFE) Reports Earnings Tomorrow: What To Expect
Global pharmaceutical company Pfizer (NYSE:PFE) will be announcing earnings results this Tuesday before market open. Here’s what to look for.
Pfizer missed analysts’ revenue expectations by 1.6% last quarter, reporting revenues of $13.72 billion, down 7.8% year on year. It was a mixed quarter for the company, with a solid beat of analysts’ organic revenue estimates but a miss of analysts’ full-year EPS guidance estimates.
Is Pfizer a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Pfizer’s revenue to grow 2.2% year on year to $13.58 billion, in line with the 2.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.57 per share.
Pfizer: Earnings Meet Pressure (Rating Upgrade) (NYSE:PFE)
Pfizer's (NYSE:PFE) stock underperformed compared to the broader since my previous writeup. However, the total return since mid-May was positive, meaning that the bearish thesis did not age as I expected. Nevertheless, I believe that Pfizer's patent cliff
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
DOEL Automatic Cat Litter Box Self Cleaning with App Control & Cat Litter Mat Smart Cat Toilet for Multiple Large Cats
The dynamic landscape of current events often brings forth significant discussions. Monitoring these developments provides crucial insights for a comprehensive understanding of evolving situations and their broader implications across various sectors.
For more detailed information and comprehensive insights, explore recent updates concerning Pfizer Reports Earnings.
For more news, visit: For more news…